---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-026104"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2024-08-12T23:59:59+00:00"
generated_at: "2026-05-31T10:03:44.190545+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Pulse Biosciences posts updated investor presentation on website; no new financial data disclosed

## Summary
- Updated deck highlights progress on CellFX nsPFA 360 Cardiac Catheter, Cardiac Surgery System, and Percutaneous Electrode.
- Investor presentation is dated August 2024 and available on company's website.
- No specific milestones, clinical data, or financial guidance included in filing.

## SEC filing metadata
- accession: 0001437749-24-026104
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2024-08-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/0001437749-24-026104-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774924026104/plse20240812_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-026104
- JSON: https://secwatch.observer/filing/0001437749-24-026104.json
- Plain text: https://secwatch.observer/filing/0001437749-24-026104.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.